These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 7937959

  • 1. The prolactin gene is expressed in the hypothalamic-neurohypophyseal system and the protein is processed into a 14-kDa fragment with activity like 16-kDa prolactin.
    Clapp C, Torner L, Gutiérrez-Ospina G, Alcántara E, López-Gómez FJ, Nagano M, Kelly PA, Mejía S, Morales MA, Martínez de la Escalera G.
    Proc Natl Acad Sci U S A; 1994 Oct 25; 91(22):10384-8. PubMed ID: 7937959
    [Abstract] [Full Text] [Related]

  • 2. Prolactin and 16K prolactin stimulate release of vasopressin by a direct effect on hypothalamo-neurohypophyseal system.
    Mejía S, Torner LM, Jeziorski MC, Gonzalez C, Morales MA, de la Escalera GM, Clapp C.
    Endocrine; 2003 Oct 25; 20(1-2):155-62. PubMed ID: 12668881
    [Abstract] [Full Text] [Related]

  • 3. Changes in the expression of neurohypophyseal prolactins during the estrous cycle and after estrogen treatment.
    Torner L, Nava G, Dueñas Z, Corbacho A, Mejía S, López F, Cajero M, Martínez de la Escalera G, Clapp C.
    J Endocrinol; 1999 Jun 25; 161(3):423-32. PubMed ID: 10333545
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immunoreactive prolactins of the neurohypophyseal system display actions characteristic of prolactin and 16K prolactin.
    López-Gómez FJ, Torner L, Mejía S, de la Escalera GM, Clapp C.
    Endocrine; 1995 Aug 25; 3(8):573-8. PubMed ID: 21153134
    [Abstract] [Full Text] [Related]

  • 8. Prolactins are natural inhibitors of angiogenesis in the retina.
    Aranda J, Rivera JC, Jeziorski MC, Riesgo-Escovar J, Nava G, López-Barrera F, Quiróz-Mercado H, Berger P, Martínez de la Escalera G, Clapp C.
    Invest Ophthalmol Vis Sci; 2005 Aug 25; 46(8):2947-53. PubMed ID: 16043870
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. 16K-prolactin inhibits activation of endothelial nitric oxide synthase, intracellular calcium mobilization, and endothelium-dependent vasorelaxation.
    Gonzalez C, Corbacho AM, Eiserich JP, Garcia C, Lopez-Barrera F, Morales-Tlalpan V, Barajas-Espinosa A, Diaz-Muñoz M, Rubio R, Lin SH, Martinez de la Escalera G, Clapp C.
    Endocrinology; 2004 Dec 25; 145(12):5714-22. PubMed ID: 15358675
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis.
    Clapp C, Martial JA, Guzman RC, Rentier-Delure F, Weiner RI.
    Endocrinology; 1993 Sep 25; 133(3):1292-9. PubMed ID: 7689950
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prolactin in eyes of patients with retinopathy of prematurity: implications for vascular regression.
    Dueñas Z, Rivera JC, Quiróz-Mercado H, Aranda J, Macotela Y, Montes de Oca P, López-Barrera F, Nava G, Guerrero JL, Suarez A, De Regil M, Martínez de la Escalera G, Clapp C.
    Invest Ophthalmol Vis Sci; 2004 Jul 25; 45(7):2049-55. PubMed ID: 15223776
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.